ANTIGENIC OSCILLATIONS AND SHIFTING IMMUNODOMINANCE IN HIV-1 INFECTIONS

被引:305
作者
NOWAK, MA
MAY, RM
PHILLIPS, RE
ROWLANDJONES, S
LALLOO, DG
MCADAM, S
KLENERMAN, P
KOPPE, B
SIGMUND, K
BANGHAM, CRM
MCMICHAEL, AJ
机构
[1] UNIV OXFORD,JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC IMMUNOL GRP,OXFORD OX3 9DU,ENGLAND
[2] UNIV VIENNA,INST MATH,A-1090 VIENNA,AUSTRIA
基金
英国惠康基金;
关键词
D O I
10.1038/375606a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A TYPICAL protein antigen contains several epitopes that can be recognized by cytotoxic T lymphocytes (CTL), but in a characteristic antiviral immune response in vivo, CTL recognize only a small number of these potential epitopes, sometimes only one(1,2), this phenomenon is known as immunodominance(1-10). Antigenic variation within CTL epitopes has been demonstrated for the human immunodeficiency virus HIV-1 (ref. 11) and other viruses(12-17) and such 'antigenic escape' may be responsible for viral persistence. Here we develop a new mathematical model that deals with the interaction between CTL and multiple epitopes of a genetically variable pathogen, acid show that the nonlinear competition among CTL responses against different epitopes can explain immunodominance. This model suggests that an antigenically homogeneous pathogen population tends to induce a dominant response against a single epitope, whereas a heterogeneous pathogen population can stimulate complicated fluctuating responses against multiple epitopes. Antigenic variation in the immunodominant epitope can shift responses to weaker epitopes and thereby reduce immunological control of the pathogen population. These ideas are consistent with detailed longitudinal studies of CTL responses in HIV-1 infected patients. For vaccine design, the model suggests that the major response should be directed against conserved epitopes even if they are subdominant.
引用
收藏
页码:606 / 611
页数:6
相关论文
共 28 条
  • [1] MECHANISMS INFLUENCING THE IMMUNODOMINANCE OF T-CELL DETERMINANTS
    ADORINI, L
    APPELLA, E
    DORIA, G
    NAGY, ZA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (06) : 2091 - 2104
  • [2] INVITRO SELECTION OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS ESCAPE MUTANTS BY CYTOTOXIC LYMPHOCYTES-T
    AEBISCHER, T
    MOSKOPHIDIS, D
    ROHRER, UH
    ZINKERNAGEL, RM
    HENGARTNER, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) : 11047 - 11051
  • [3] BANGHAM CRM, 1989, T CELLS, P281
  • [4] NATURAL VARIANTS OF CYTOTOXIC EPITOPES ARE T-CELL RECEPTOR ANTAGONISTS FOR ANTIVIRAL CYTOTOXIC T-CELLS
    BERTOLETTI, A
    SETTE, A
    CHISARI, FV
    PENNA, A
    LEVRERO, M
    DECARLI, M
    FIACCADORI, F
    FERRARI, C
    [J]. NATURE, 1994, 369 (6479) : 407 - 410
  • [5] THE RELATION BETWEEN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) RESTRICTION AND THE CAPACITY OF IA TO BIND IMMUNOGENIC PEPTIDES
    BUUS, S
    SETTE, A
    COLON, SM
    MILES, C
    GREY, HM
    [J]. SCIENCE, 1987, 235 (4794) : 1353 - 1358
  • [6] CAMPOSLIMA P, 1993, SCIENCE, V260, P98
  • [7] Carpenter S., 1990, Applied Virology Research, V2, P99
  • [8] Gegin Cem, 1992, Journal of Immunology, V149, P3331
  • [9] IR(1) GENES, PERIPHERAL CROSS-TOLERANCE AND IMMUNODOMINANCE IN MHC CLASS I-RESTRICTED T-CELL RESPONSES - AN OLD QUAGMIRE REVISITED
    HILL, AB
    MULLBACHER, A
    BLANDEN, RV
    [J]. IMMUNOLOGICAL REVIEWS, 1993, 133 : 75 - 91
  • [10] CYTOTOXIC T-CELL ACTIVITY ANTAGONIZED BY NATURALLY-OCCURRING HIV-1 GAG VARIANTS
    KLENERMAN, P
    ROWLANDJONES, S
    MCADAM, S
    EDWARDS, J
    DAENKE, S
    LALLOO, D
    KOPPE, B
    ROSENBERG, W
    BOYD, D
    EDWARDS, A
    GIANGRANDE, P
    PHILLIPS, RE
    MCMICHAEL, AJ
    [J]. NATURE, 1994, 369 (6479) : 403 - 407